Dealing with a new diagnosis or confusing lab numbers? Talk with people who have been there. Compare nerve, joint, and migraine recovery logs from real patients—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Migraine, Pain & Joints Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Migraine, Pain & Joints Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data
← All Conditions (3,135) / Rheumatoid Arthritis, Lupus & Autoimmune

Rheumatoid Arthritis, Lupus & Autoimmune (68 Condition Guides)

Rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, Sjögren syndrome, and biologics.

Interactive MyChart Lab & Cuff Translator • Lab Bell-Curve “Normal” vs. Physiological Optimal

Why Your Portal Says “Normal” When You Still Feel Awful: Enter Your Number

Quest and LabCorp “Normal” ranges are 95% population bell curves—not physiological optimums. Select a marker and type your result below:

3-Zone Clinical Cutoff Audit • Serum Ferritin (Iron Storage)

18 ng/mL = Marked "Normal" by Lab, Yet Clinically Depleted (< 30–50 ng/mL)

Default Sample: 18 ng/mL
Zone 1 • Clinical Cutoff
< 15 ng/mL • Overt Deficiency
< 15 ng/mL (Absolute Depletion)
Zone 2 • Portal “Normal” Gray Zone
15–49 ng/mL • "Normal" Yet Depleted
15–150 ng/mL (Quest/LabCorp Bell Curve)
Zone 3 • Physiological Optimal
50–100 ng/mL • Clinical Optimal
50–100 ng/mL (Physiological Optimal)
What This Number Means in Plain English

Commercial labs only flag Ferritin below 15 ng/mL, but clinical trials confirm fatigue, restless legs, diffuse telogen hair shedding, and impaired T4-to-T3 thyroid conversion begin whenever Ferritin drops below 30–50 ng/mL.

Action Plan: Take 25–28 mg elemental Iron Bisglycinate on alternate mornings (Mon/Wed/Fri) with Vitamin C to bypass the 24-hour hepcidin block, then re-test in 8–12 weeks.

⚠ Lab Assay & Cuff False-Alarm Check

Acute inflammation, viral illness, or fatty liver artificially elevates Ferritin (it is an acute-phase reactant). Always pair Ferritin with Fasting Transferrin Saturation (TSAT) and hs-CRP.

Specialty Directory

Rheumatoid Arthritis, Lupus & Autoimmune Guides (68)

Clear Filter × Page 2 of 2

Sarcoid iridocyclitis

Sarcoid iridocyclitis (ICD-10-CM D86.83) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Sarcoid meningitis

Sarcoid meningitis—coded clinically as D86.81 across Autoimmune Disease guidelines—combines early treat-to-target disease-modifying in Sarcoid meningitis (D86.81: antirheumatic (DMARD/biologic) therapy) with structured follow-up of hs-CRP & ESR [Sarcoid meningitis D86.81] (hs-CRP < 1.0 mg/L; ESR < 15 mm/hr (D86.81)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Sarcoid myocarditis

Sarcoid myocarditis (ICD-10-CM D86.85) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Sarcoid myositis

Designated in federal medical registries as D86.87, Sarcoid myositis falls under Autoimmune Disease management, where acute-phase reactants [Sarcoid myositis D86.87] establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Sarcoid pyelonephritis

Sarcoid pyelonephritis—coded clinically as D86.84 across Autoimmune Disease guidelines—combines musculoskeletal ultrasound/MRI synovitis in Sarcoid pyelonephritis (D86.84: grading) with structured follow-up of ANA, RF, Anti-CCP in Sarcoid pyelonephritis (D86.84: & Complement C3/C4) (Disease-activity remission targets (D86.84)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Sarcoidosis

Sarcoidosis is a condition in which groups of cells in your immune system form small, red, and swollen (inflamed) lumps. These lumps are called granulomas. They can form in any organ in the body. But they most commonly affect the lungs and lymph nodes in the chest. Over time, sarcoidosis can cause permanent scarring of organs. What causes sarcoidosis? Your immune system creates inflammation to help defend you against germs and sickness. But in sarcoidosis, inflammation goes off track. It causes the cells in your immune system to form granulomas.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Sarcoidosis of lung

Designated in federal medical registries as D86.0, Sarcoidosis of lung falls under Autoimmune Disease management, where musculoskeletal ultrasound/MRI synovitis in Sarcoidosis of lung (D86.0: grading) establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Sarcoidosis of lung with sarcoidosis of lymph nodes

Sarcoidosis of lung with sarcoidosis of lymph nodes (ICD-10-CM D86.2) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Sarcoidosis of lymph nodes

Sarcoidosis of lymph nodes (ICD-10-CM D86.1) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Sarcoidosis of other sites

Sarcoidosis of other sites (ICD-10-CM D86.89) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Sarcoidosis of skin

Designated in federal medical registries as D86.3, Sarcoidosis of skin falls under Autoimmune Disease management, where early treat-to-target disease-modifying in Sarcoidosis of skin (D86.3: antirheumatic (DMARD/biologic) therapy) establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Scleroderma

Also called: Circumscribed scleroderma • Dermatosclerosis • Systemic sclerosis

Scleroderma means "hard skin." It's the name of an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. This inflammation causes you to have areas of tight, hard skin. Scleroderma may affect just one area of your body, or it can affect many systems in your body. What are the types of scleroderma? There are two main types of scleroderma: Localized scleroderma only affects your skin and the muscles and tissues just under your skin. Systemic scleroderma, which is also called systemic sclerosis, is a more serious type.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Sjogren syndrome with gastrointestinal involvement

Sjogren syndrome with gastrointestinal involvement (ICD-10-CM M35.08) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Sjogren syndrome with keratoconjunctivitis

Sjogren syndrome with keratoconjunctivitis (ICD-10-CM M35.01) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Sjogren syndrome with lung involvement

Sjogren syndrome with lung involvement (ICD-10-CM M35.02) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Sjogren syndrome with myopathy

Sjogren syndrome with myopathy (ICD-10-CM M35.03) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Sjogren syndrome with other organ involvement

Sjogren syndrome with other organ involvement (ICD-10-CM M35.09) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Sjogren syndrome with tubulo-interstitial nephropathy

Sjogren syndrome with tubulo-interstitial nephropathy (ICD-10-CM M35.04) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Sjögren's Disease

Also called: Sjögren's syndrome

Sjögren's disease, previously called Sjögren's syndrome, is a chronic (long-lasting) autoimmune disease. When you have an autoimmune disease, your immune system attacks healthy tissues and organs by mistake. In Sjögren's disease, your immune system attacks the glands that make moisture in the eyes, mouth, and other parts of the body. This causes a dry mouth and dry eyes. You may have dryness in other places that need moisture, such as your nose, throat, and skin. Sjögren's disease can also affect other parts of the body, including your joints, lungs, kidneys, blood vessels, digestive organs, and nerves.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Sjögren's syndrome

Sjögren's syndrome (ICD-10-CM M35.00) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Systemic involvement of connective tissue

Systemic involvement of connective tissue (ICD-10-CM M35.9) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Systemic lupus erythematosus (SLE)

Also called: Systemic lupus erythematosus

Systemic lupus erythematosus (SLE)—coded clinically as M32.9 across Autoimmune Disease guidelines—combines early treat-to-target disease-modifying in Systemic lupus erythematosus (SLE) (M32.9: antirheumatic (DMARD/biologic) therapy) with structured follow-up of CBC, ALT & in Systemic lupus erythematosus (SLE) (M32.9: Creatinine (DMARD safety)) (Within normal safety monitoring limits (M32.9)).

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Systemic sclerosis induced by drug and chemical

Systemic sclerosis induced by drug and chemical (ICD-10-CM M34.2) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Systemic sclerosis with lung involvement

Systemic sclerosis with lung involvement—coded clinically as M34.81 across Autoimmune Disease guidelines—combines musculoskeletal ultrasound/MRI synovitis in Systemic sclerosis with lung involvement (M34.81: grading) with structured follow-up of ANA, RF, Anti-CCP in Systemic sclerosis with lung involvement (M34.81: & Complement C3/C4) (Disease-activity remission targets (M34.81)).

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Systemic sclerosis with myopathy

Systemic sclerosis with myopathy (ICD-10-CM M34.82) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Systemic sclerosis with polyneuropathy

Designated in federal medical registries as M34.83, Systemic sclerosis with polyneuropathy falls under Autoimmune Disease management, where early treat-to-target disease-modifying in Systemic sclerosis with polyneuropathy (M34.83: antirheumatic (DMARD/biologic) therapy) establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Tubulo-interstitial nephropathy in systemic lupus erythematosus

Designated in federal medical registries as M32.15, Tubulo-interstitial nephropathy in systemic lupus erythematosus falls under Autoimmune Disease management, where early treat-to-target disease-modifying in Tubulo-interstitial nephropathy in systemic lupus erythematosus (M32.15: antirheumatic (DMARD/biologic) therapy) establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Vasculitis

Also called: Angiitis

Vasculitis is an inflammation of the blood vessels. It happens when the body's immune system attacks the blood vessel by mistake. It can happen because of an infection, a medicine, or another disease. The cause is often unknown. Vasculitis can affect arteries, veins and capillaries. Arteries are vessels that carry blood from the heart to the body's organs. Veins are the vessels that carry blood back to the heart. Capillaries are tiny blood vessels that connect the small arteries and veins. When a blood vessel becomes inflamed, it can: Narrow, making it more difficult for blood to get through. Close off completely so that blood can't get through.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Vasculitis - leukocytoclastic

Vasculitis - leukocytoclastic—coded clinically as M31.0 across Autoimmune Disease guidelines—combines early treat-to-target disease-modifying in Vasculitis - leukocytoclastic (M31.0: antirheumatic (DMARD/biologic) therapy) with structured follow-up of hs-CRP & ESR [Vasculitis - leukocytoclastic M31.0] (hs-CRP < 1.0 mg/L; ESR < 15 mm/hr (M31.0)).

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy

Weber-Christian disease

Weber-Christian disease (ICD-10-CM M35.6) is evaluated within Rheumatoid Arthritis, Lupus & Autoimmune using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Progressive load management & physical therapy + targeted anti-inflammatory or disease-modifying therapy
Connected Clinical Ecosystem • Medications, Supplements & Specialists

Go From Diagnosis to Treatment: Connected Flagship Guides

Prescription Medications (/meds)

FDA DailyMed & NADAC Cash Price Guides

Decode tablet imprints, IR vs. ER stomach side effects, Rule-of-6 dose response curves, and $3–$9 generic cash prices.

Dietary Supplements (/supplements)

NIH ODS & Elemental Label Math Guides

Separate human RCT outcomes from social media hype—with elemental vs. compound weight decoders and serum 25(OH)D targets.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Compare U.S. specialists by real CMS Medicare Part B procedure volume, verified Google patient reviews, and accepted PPO/Medicare plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

Which diagnostic lab ranges and guidelines govern Rheumatoid Arthritis, Lupus & Autoimmune on dotMD.com?

dotMD.com maps Rheumatoid Arthritis, Lupus & Autoimmune against ADA, ACC/AHA, USPSTF, and Endocrine Society diagnostic criteria, contrasting broad 95% portal reference intervals with optimal clinical targets. Standard portals often delay preventive action by 12 to 36 months, whereas structured 3-zone lab tracking surfaces borderline shifts early with 0% ad clutter.

Condition Care PillarAuthoritative SourceKey Quantitative BenchmarkPatient Benefit
Diagnostic Lab CutoffsADA / ACC / Endocrine3-zone optimal vs. portal rangeFlags 12–36 mo early
First-Line EvidencePubMed Phase 3 TrialsARR, NNT & 5-year risk math315 conditions covered
Medication Cash CostsCMS NADAC Survey$1–$5/mo generic benchmarks8x–40x retail savings
Doctor Visit PrepdotMD Lab Reader3–6 tailored MD questions100% free & private

How should patients prepare lab numbers and questions for a Rheumatoid Arthritis, Lupus & Autoimmune visit?

dotMD.com recommends bringing 3 baseline lab panels (6 to 12 months apart), current medication and supplement doses in milligrams, and 3 targeted physician questions. Auditing treatment options by Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) clarifies real 5-year benefit in under 5 mins.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee